approval
saveGLEEVEC (IMATINIB MESYLATE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalJan 14, 2026 · 264d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 19, 2022 · 1508d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 24, 2022 · 1656d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2247d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2247d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 21, 2018 · 2967d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 29, 2017 · 3293d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 6, 2017 · 3316d ago
same company · ±60 days · 6
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalFeb 27, 2024
- approvalSpexotras: MEKINIST (TRAMETINIB) — FDA approvalFeb 27, 2024
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalFeb 27, 2024
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalFeb 27, 2024
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 29, 2024
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalMar 29, 2024
comments(0)
5-min edit window · permanent after that